A daily weight loss pill that works like breakthrough fat jab Ozempic can help users lose an average of almost two stones (12.4kg), a study reveals.
People taking the new wonder drug orforglipron lost an average of 12.4 per cent of their body weight after 72 weeks in a groundbreaking final stage trial.
The participants, who were overweight but did not have diabetes, also benefited from reductions in bad cholesterol, blood fats and blood pressure.
Manufacturer Lilly said the once-a-day pill—the first of its kind—could be launched ‘at scale’ worldwide and ‘without supply constraints’ as early as next year.
It now plans to apply for regulatory approval within months. Previous studies examined patients with diabetes.
